Trial intelligence / Profile preview

Micafungin PK in Overweight and Obese Volunteers

NCT01090141Phase 4Completed

Sponsor
UT Southwestern Medical Center
Start
Nov 2009
Primary completion
May 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of micafungin in fungal infection (2 arms), sponsored by UT Southwestern Medical Center. Primary endpoint: Serum Clearance at 24 hours. Started Nov 2009; status: completed.

02

Drugs

micafungin
03

Conditions

fungal infection

Beyond the preview

Go deeper on NCT01090141.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01090141.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call